XG Sciences Appoints Dr. Philip L. Rose as Chief Executive Officer
Leading graphene-based products manufacturer hires new CEO.
Lansing, MI (PRWEB) January 14, 2014
XG Sciences, a leader in the field of graphene and graphene-based products, has named Philip L. Rose as chief executive officer.
“We are pleased to welcome Philip to XG Sciences,” said Mike Knox, co-founder and former CEO. “He brings an invaluable combination of scientific and management expertise that will allow him to oversee all aspects of our continued business development. His experience in the advanced materials space as well as his strong customer focus makes him the ideal choice to lead XG Sciences through the next stage of its commercial development.”
Rose joins XG Sciences after serving as president of Sigma-Aldrich, SAFC Hitech in St. Louis, where he also held concurrent positions as chairman and chief executive officer of Sigma-Aldrich’s joint venture with Korea-based Soulbrain. Prior to that, he excelled in a number of senior business development and marketing positions for Rohm and Haas and Shipley in the United States and Asia.
A graduate of Duke University (Ph.D. in Physical Chemistry) and the University of Southern California (B.S. in Chemistry), Rose has also completed the Wharton Management Program at the University of Pennsylvania’s Wharton School of Business.
XG Sciences manufactures energy storage materials based on the company’s xGnP® graphene nanoplatelets and XG Leaf™ graphene sheet products. XG Sciences Inc. is a leading supplier of graphene nanoplatelets and custom, graphene-based products to global corporations serving energy storage, aerospace, automotive, industrial and consumer markets. In addition to its electrode materials, XG Sciences makes thermal management materials, and electrically and thermally conductive inks, coatings and adhesives based on its graphene nanoplatelets. For evaluation materials and technical support, please visit http://www.xgsciences.com or contact info(at)xgsciences.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/xgsciences/philiprose/prweb11485031.htm